These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

346 related items for PubMed ID: 28733126

  • 21. Emergence and management of drug-resistant enterococcal infections.
    Arias CA, Murray BE.
    Expert Rev Anti Infect Ther; 2008 Oct; 6(5):637-55. PubMed ID: 18847403
    [Abstract] [Full Text] [Related]

  • 22. [Phenotypic and genotypic traits of vancomycin-resistant enterococci in a public hospital: the first vanB-positive Enterococcus faecium isolates].
    Coşkun FA, Mumcuoğlu I, Aksu N, Karahan ZC, Us E, Tekeli FA, Baran I, Kanyılmaz D, Kurşun S.
    Mikrobiyol Bul; 2012 Apr; 46(2):276-82. PubMed ID: 22639316
    [Abstract] [Full Text] [Related]

  • 23. Trends in antimicrobial resistance of clinical isolates of Enterococcus faecalis and Enterococcus faecium in Greece between 2002 and 2007.
    Protonotariou E, Dimitroulia E, Pournaras S, Pitiriga V, Sofianou D, Tsakris A.
    J Hosp Infect; 2010 Jul; 75(3):225-7. PubMed ID: 20381193
    [Abstract] [Full Text] [Related]

  • 24. The in-vitro activity of LY333328, a new glycopeptide, against clinical isolates of vancomycin-resistant enterococci.
    Kirk M, Hill RL, Casewell MW, Beighton D.
    Adv Exp Med Biol; 1997 Jul; 418():483-5. PubMed ID: 9331699
    [No Abstract] [Full Text] [Related]

  • 25. A comparative review of the lipoglycopeptides: oritavancin, dalbavancin, and telavancin.
    Guskey MT, Tsuji BT.
    Pharmacotherapy; 2010 Jan; 30(1):80-94. PubMed ID: 20030476
    [Abstract] [Full Text] [Related]

  • 26. Antimicrobial Activity of Dalbavancin against Staphylococcus aureus with Decreased Susceptibility to Glycopeptides, Daptomycin, and/or Linezolid from U.S. Medical Centers.
    Sader HS, Mendes RE, Duncan LR, Pfaller MA, Flamm RK.
    Antimicrob Agents Chemother; 2018 Mar; 62(3):. PubMed ID: 29263077
    [Abstract] [Full Text] [Related]

  • 27. Clinical implications of vancomycin-resistant Enterococcus faecium (VRE) with VanD phenotype and vanA genotype.
    Song JH, Ko KS, Suh JY, Oh WS, Kang CI, Chung DR, Peck KR, Lee NY, Lee WG.
    J Antimicrob Chemother; 2008 Apr; 61(4):838-44. PubMed ID: 18230690
    [Abstract] [Full Text] [Related]

  • 28. [Investigation of phenotypic and genotypic characteristics of vancomycin-resistant Enterococcus faecium isolates].
    Aktaş Z, Diyarbakirli P, Bal C, Gürler N, Keser M, Somer A, Salman N.
    Mikrobiyol Bul; 2007 Jul; 41(3):347-56. PubMed ID: 17933244
    [Abstract] [Full Text] [Related]

  • 29. Activity of dalbavancin and comparator agents against Gram-positive cocci from clinical infections in the USA and Europe 2015-16.
    Pfaller MA, Mendes RE, Duncan LR, Flamm RK, Sader HS.
    J Antimicrob Chemother; 2018 Oct 01; 73(10):2748-2756. PubMed ID: 29982565
    [Abstract] [Full Text] [Related]

  • 30. Beyond Vancomycin: The Tail of the Lipoglycopeptides.
    Klinker KP, Borgert SJ.
    Clin Ther; 2015 Dec 01; 37(12):2619-36. PubMed ID: 26658277
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Activity of telavancin against staphylococci and enterococci determined by MIC and resistance selection studies.
    Kosowska-Shick K, Clark C, Pankuch GA, McGhee P, Dewasse B, Beachel L, Appelbaum PC.
    Antimicrob Agents Chemother; 2009 Oct 01; 53(10):4217-24. PubMed ID: 19620338
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Time-kill study and synergistic activity of cell-wall inhibitor antibiotics in combination with gentamicin against Enterococcus faecalis and Enterococcus faecium.
    Aligholi M, Emaneini M, Taherikalani M, Shahsavan S, Jabalameli F, Asadollahi P, Khoramian B, Eslampour MA.
    Acta Microbiol Immunol Hung; 2011 Sep 01; 58(3):219-26. PubMed ID: 21983323
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Outbreak in a haematology unit involving an unusual strain of glycopeptide-resistant Enterococcus faecium carrying both vanA and vanB genes.
    Marcadé G, Micol JB, Jacquier H, Raskine L, Donay JL, Nicolas-Viaud S, Rouveau M, Ribaud P, Dombret H, Leclercq R, Cambau E.
    J Antimicrob Chemother; 2014 Feb 01; 69(2):500-5. PubMed ID: 24092659
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.